FIELD: pharmacology.
SUBSTANCE: invention relates to a fluoroquinolone carboxylic acid derivative, namely 1-ethyl-6-fluoro-4-oxo-7-(8-ethoxy-2-oxo-2H-chromen-3-yl)-1,4-dihydroquinoline-3 carboxylic acid of formula
.
EFFECT: high antitubercular activity, including that with respect to strains of mycobacteria with multiple drug resistance.
2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
5-FLUORO-2-(4-ETHOXYCARBONYLDIPIPERAZINE-1-YL)-1,3-BENZOTHIAZINE-4-ONE, WHICH HAS ANTI-TUBERCULOSIS ACTIVITY | 2018 |
|
RU2663848C1 |
N-(2-AMINOPURIN-6-YL)GLYCYL-(S)-GLUTAMIC ACID, HAVING ANTI-TUBERCULOSIS ACTIVITY | 2015 |
|
RU2604068C1 |
N-(2-ACETAMIDOPURIN-6-YL)GLYCINE, WHICH HAS ANTI-TUBERCULOSIS ACTIVITY | 2014 |
|
RU2570113C1 |
3-TRIAZENONE INDOLES POSSESSING MYCOBACTERIUM ACTIVITY | 2016 |
|
RU2724334C1 |
SELECTIVE ANTI-TUBERCULOSIS AGENTS, REPRESENTING 3-AMINOSUBSTITUTED 6-(3,5-DIMETHYLPYRAZOL-1-YL)-1,2,4,5-TETRAZINES | 2012 |
|
RU2519218C2 |
CHLORIDE 4-[(1E)-1-(6-CHLORO-4-OXO-4N-CHROMEN-3-YL)-4-METHYLPENT-1-EN-3-YL]MORPHOLINE-4-YL, METHOD OF PRODUCING THEREOF AND ITS ANTITUBERCULOSIS EFFECT | 2016 |
|
RU2613633C1 |
SELECTIVE ANTITUBERCULOSIS AGENT REPRESENTING 3-HYDRAZONO-6-(3,5-DIMETHYLPYRAZOL-1-YL)- 1,2,4,5-TETRAZINE AND METHOD FOR PREPARING IT | 2011 |
|
RU2479311C2 |
ANTI-TUBERCULOSIS AGENTS BEING 3,7-DISUBSTITUTED [1,2,4]TRIAZOLO[1,5-b][1,2,4,5]TETRAZINES | 2022 |
|
RU2802300C1 |
α,ω-BIS(AMIDE- AND HYDRAZIDE METHYL SULFINYL- AND SULPHONYL) ALKANES HAVING ANTI-TUBERCULOSIS ACTIVITY, AND α,ω-BIS(METHOXY CARBONYL METHYL SULFINYL- OR SULPHONYL) ALKANES FOR PRODUCTION THEREOF | 2015 |
|
RU2591256C1 |
5-ARYL-4-FLUOROISOXAZOLES AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2708456C1 |
Authors
Dates
2018-01-25—Published
2017-03-21—Filed